Citizens & Northern Corp’s Bristol-Myers Squibb BMY Stock Holding History

Citizens & Northern Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Buy	23,628 +4,631	+24%	+$266K	0.31%	62
2026 Q1	$1.15M	Sell	18,997 -54	-0.3%	-$3.15K	0.29%	69
2025 Q4	$1.03M	Sell	19,051 -554	-3%	-$26.7K	0.25%	78
2025 Q3	$884K	Sell	19,605 -41	-0.2%	-$1.92K	0.22%	82
2025 Q2	$909K	Buy	19,646 +204	+1%	+$10K	0.24%	79
2025 Q1	$1.19M	Buy	19,442 +322	+2%	+$18.8K	0.33%	63
2024 Q4	$1.08M	Buy	19,120 +5,026	+36%	+$281K	0.3%	73
2024 Q3	$729K	Sell	14,094 -3,787	-21%	-$178K	0.22%	82
2024 Q2	$743K	Sell	17,881 -813	-4%	-$36.4K	0.23%	90
2024 Q1	$1.01M	Sell	18,694 -536	-3%	-$27.3K	0.34%	71
2023 Q4	$987K	Sell	19,230 -882	-4%	-$46.3K	0.35%	65
2023 Q3	$1.17M	Sell	20,112 -790	-4%	-$48.4K	0.47%	58
2023 Q2	$1.34M	Sell	20,902 -95	-0.5%	-$6.37K	0.51%	55
2023 Q1	$1.46M	Buy	20,997 +206	+1%	+$14.5K	0.57%	46
2022 Q4	$1.5M	Buy	20,791 +44	+0.2%	+$3.32K	0.62%	45
2022 Q3	$1.48M	Sell	20,747 -226	-1%	-$16.4K	0.69%	40
2022 Q2	$1.61M	Sell	20,973 -11	-0.1%	-$838	0.7%	39
2022 Q1	$1.53M	Sell	20,984 -488	-2%	-$32.8K	0.57%	45
2021 Q4	$1.34M	Sell	21,472 -2,519	-10%	-$148K	0.48%	55
2021 Q3	$1.42M	Sell	23,991 -490	-2%	-$32.3K	0.54%	50
2021 Q2	$1.64M	Sell	24,481 -1,798	-7%	-$117K	0.61%	45
2021 Q1	$1.66M	Sell	26,279 -568	-2%	-$35.3K	0.66%	42
2020 Q4	$1.67M	Buy	26,847 +656	+3%	+$40.3K	0.73%	38
2020 Q3	$1.58M	Sell	26,191 -1,070	-4%	-$64.4K	0.84%	36
2020 Q2	$1.6M	Sell	27,261 -267	-1%	-$16K	0.78%	40
2020 Q1	$1.53M	Sell	27,528 -1,270	-4%	-$77.6K	0.97%	34
2019 Q4	$1.85M	Buy	28,798 +853	+3%	+$48.9K	0.93%	30
2019 Q3	$1.42M	Sell	27,945 -943	-3%	-$44.3K	0.77%	43
2019 Q2	$1.31M	Sell	28,888 -629	-2%	-$29.3K	0.73%	44
2019 Q1	$1.41M	Buy	29,517 +1,819	+7%	+$90.6K	0.79%	44
2018 Q4	$1.44M	Sell	27,698 -1,124	-4%	-$60.4K	1%	31
2018 Q3	$1.79M	Sell	28,822 -1,974	-6%	-$117K	1.22%	32
2018 Q2	$1.7M	Buy	30,796 +2,861	+10%	+$155K	1.21%	28
2018 Q1	$1.77M	Buy	27,935 +909	+3%	+$58.5K	1.31%	25
2017 Q4	$1.66M	Buy	27,026 +654	+2%	+$40.9K	1.18%	33
2017 Q3	$1.68M	Buy	26,372 +654	+3%	+$38.2K	1.28%	26
2017 Q2	$1.43M	Buy	25,718 +1,260	+5%	+$68.6K	1.13%	34
2017 Q1	$1.33M	Buy	+24,458	New	+$1.34M	1.07%	38

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Citizens & Northern Corp's BMY Position: Q2 2026 in Review

Citizens & Northern Corp increased its Bristol-Myers Squibb (BMY) stake by 24% in Q2 2026, buying an estimated $266K and bringing the position to 23,628 shares worth $1.36M. The position accounts for 0.31% of the portfolio, ranked #62.

Citizens & Northern Corp first reported a position in BMY in Q1 2017 and has held it in 38 quarters since. The position peaked at $1.85M in Q4 2019. 888 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Citizens & Northern Corp held 23,628 shares of Bristol-Myers Squibb worth $1.36M as of Q2 2026.
Citizens & Northern Corp bought 4,631 Bristol-Myers Squibb shares in Q2 2026, an estimated $266K.
Bristol-Myers Squibb made up 0.31% of Citizens & Northern Corp's portfolio in Q2 2026, its #62 holding.
Citizens & Northern Corp first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 38 quarters since.
Citizens & Northern Corp's Bristol-Myers Squibb position peaked at $1.85M in Q4 2019.
888 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Citizens & Northern Corp's 13F filing for Q2 2026, filed 17 Jul 2026.